Auriga Reiterates Hold on athenahealth

Auriga is out with its report today on aurigahealth ATHN, reiterating Hold. In a note to clients, Auriga writes, "We are reiterating our HOLD rating on athenahealth on the heels of last week's contract expansion with University Hospitals and in advance of earnings on July 21. While the contract represents a nice enterprise win at a meaningful customer, we caution that some level of enterprise deals (in addition to cross-selling) will likely be a 'must-have', rather than a 'nice-to-have' to maintain the company's 30% top-line growth targets." Auriga maintains a $45 PT on ATHN. Shares of ATHN closed Friday at $46.93.